Complex Femoropopliteal PAD and Role of Drug Delivering Therapies

September 3, 2020 – September 3, 2021


This activity has been designed to meet the educational needs of cardiologists, surgeons, internists, trainees, investigators, and allied health care workers who participate in the care of patients with coronary, peripheral, and structural cardiovascular diseases.


The goal of this activity is to provide participants with knowledge on how to evaluate and treat patients with coronary artery disease, peripheral vascular disease, and valvular, structural heart and arrhythmic heart disease.


  • Define current atherectomy devices, pros and cons
  • Explain the importance of vessel prep and its impact patency
  • Describe the roles of Interwoven stent, DCB + BMS, DES for complex disease


This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of CMEsolutions and Cardiovascular Innovations Foundation. The CMEsolutions is accredited by the ACCME to provide continuing medical education for physicians.

The CMEsolutions designates this enduring activity for a maximum of 1 AMA PRA Category 1 Credits.™ Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Start Date: September 3, 2020           End Date: September 3, 2021


  1. View presentations
  2. At the end of the webinar, login to:
  3. Complete the Evaluation/Credit Request Form
  4. Download or Print Credit Statement. No credit requests will be accepted after September 3, 2021


Sudhash Banerjee, MD
Chief of Cardiology, VA North Texas Health Care System
Dallas, TX
Sudhash Banerjee has disclosed the following relevant financial relationships:  AstraZeneca-Speaker Bureau; Boston Scientific-Institutional Research Grant; Livmore, Inc.-Consultant

Karem C. Harth, MD, MHS, RPVI
Assistant Professor of Surgery, Medical Director HHVI Vascular Laboratories, University Hospitals Cleveland Medical Center
Cleveland, OH
Karem Harth has no relevant financial relationships to disclose.

Carlos Mena, MD
Interventional cardiologist and director of the peripheral vascular disease program, Yale University
New Haven, CT
Carlos Mena has no relevant financial relationships to disclose.

Constantino S. Pena, MD
Interventional Cardiologist, Miami Cardiac and Vascular Institute
Miami, FL
Constantino S. Pena has no relevant financial relationships to disclose.

Mehdi Shishehbor, DO, MPH, PhD
Director, Cardiovascular Interventional Center, University Hospitals Cleveland Medical Center
Cleveland, OH
Mehdi Shishehbor has no relevant financial relationships to disclose.

Ramon L. Varcoe, MBBS, MS, PhD
Vascular Surgeon, Prince of Wales Hospital University of New South Wales
Randwick, New South Wales
Ramon L. Varcoe has no relevant financial relationships to disclose.

Planner Disclosures

No member of CMEsolutions or Cardiovascular Innovations Foundation has any relevant financial relationships to disclose in regards to this activity.

Kelly Desatnik
Program Director, Cardiovascular Innovations Foundation
Denver, CO
No relevant financial relationships to disclose.

Joel Brill, MD, FACP
Professor of Medicine, University of Arizona and Midwestern University
Scottsdale, AZ
No relevant financial relationships to disclose.

Christopher King, BS
Managing Partner, CMEsolutions
Camden, ME
No relevant financial relationships to disclose.

Off-label Use

This activitymay contain discussion of unlabeled and/or investigational uses of agents not approved by the FDA.  Please consult the prescribing information for each product.

Commercial Support

Commercial Support for this educational activity will be provided by the following:

  • Boston Scientific
  • Medtronic

Privacy Policy

CMEsolutions Privacy and Confidentiality Policy:
CMEsolutions can be contacted at .

 complete evaluation/credit request